Nigam, S.; Bishop, J.O.; Hayat, H.; Quadri, T.; Hayat, H.; Wang, P.
Nanotechnology in Immunotherapy for Type 1 Diabetes: Promising Innovations and Future Advances. Pharmaceutics 2022, 14, 644.
https://doi.org/10.3390/pharmaceutics14030644
AMA Style
Nigam S, Bishop JO, Hayat H, Quadri T, Hayat H, Wang P.
Nanotechnology in Immunotherapy for Type 1 Diabetes: Promising Innovations and Future Advances. Pharmaceutics. 2022; 14(3):644.
https://doi.org/10.3390/pharmaceutics14030644
Chicago/Turabian Style
Nigam, Saumya, Jack Owen Bishop, Hanaan Hayat, Tahnia Quadri, Hasaan Hayat, and Ping Wang.
2022. "Nanotechnology in Immunotherapy for Type 1 Diabetes: Promising Innovations and Future Advances" Pharmaceutics 14, no. 3: 644.
https://doi.org/10.3390/pharmaceutics14030644
APA Style
Nigam, S., Bishop, J. O., Hayat, H., Quadri, T., Hayat, H., & Wang, P.
(2022). Nanotechnology in Immunotherapy for Type 1 Diabetes: Promising Innovations and Future Advances. Pharmaceutics, 14(3), 644.
https://doi.org/10.3390/pharmaceutics14030644